메뉴 건너뛰기




Volumn 99, Issue 5, 2014, Pages 821-829

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): A Bone Marrow Pathology Group study

(21)  Rogers, Heesun J a   Vardiman, James W b   Anastasi, John b   Raca, Gordana b   Savage, Natasha M c   Cherry, Athena M c   Arber, Daniel c   Moore, Erika d   Morrissette, Jennifer J D d   Bagg, Adam d   Liu, Yen Chun e   Mathew, Susan e   Orazi, Attilio e   Lin, Pei f   Wang, Sa A f   Bueso Ramos, Carlos E f   Foucar, Kathryn g   Hasserjian, Robert P h   Tiu, Ramon V i   Karafa, Matthew a   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; DEATH; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTICENTER STUDY (TOPIC); MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; BONE MARROW; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CLINICAL TRIAL; FOLLOW UP; GENE TRANSLOCATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROMES; OUTCOME ASSESSMENT; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

EID: 84899720825     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.096420     Document Type: Article
Times cited : (67)

References (38)
  • 1
    • 62249168182 scopus 로고    scopus 로고
    • Acute myeloid leukaemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2)
    • In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, eds, 4th ed. Lyon, France: IARC Press
    • Arber DA, Vardiman JW, Brunning DR, Porwit A, Le Beau MM, Thiele J, et al. Acute myeloid leukaemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008, p110-8.
    • (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , pp. 110-118
    • Arber, D.A.1    Vardiman, J.W.2    Brunning, D.R.3    Porwit, A.4    Le Beau, M.M.5    Thiele, J.6
  • 2
    • 79961012609 scopus 로고    scopus 로고
    • Myelodysplastic syndrome With inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2) has a high risk for progression to acute myeoid leukemia
    • Cui W, Sun J, Cotta CV, Medeiros LJ, Lin P. Myelodysplastic syndrome With inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2) has a high risk for progression to acute myeoid leukemia. Am J Clin Pathol. 2011; 136(2): 282-8.
    • (2011) Am J Clin Pathol , vol.136 , Issue.2 , pp. 282-288
    • Cui, W.1    Sun, J.2    Cotta, C.V.3    Medeiros, L.J.4    Lin, P.5
  • 3
    • 36048977071 scopus 로고    scopus 로고
    • Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3; 3) (q21; q26) positive AML
    • Weisser M, Haferlach C, Haferlach T, Schnittger S. Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3; 3) (q21; q26) positive AML. Leuk Lymphoma. 2007; 48(11): 2145-51.
    • (2007) Leuk Lymphoma , vol.48 , Issue.11 , pp. 2145-2151
    • Weisser, M.1    Haferlach, C.2    Haferlach, T.3    Schnittger, S.4
  • 4
    • 0032833342 scopus 로고    scopus 로고
    • 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: Biological and clinical features
    • Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica. 1999; 84(8): 690-4.
    • (1999) Haematologica , vol.84 , Issue.8 , pp. 690-694
    • Testoni, N.1    Borsaru, G.2    Martinelli, G.3    Carboni, C.4    Ruggeri, D.5    Ottaviani, E.6
  • 5
    • 77956247735 scopus 로고    scopus 로고
    • Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia
    • Lugthart S, Groschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010; 28(24): 3890-8.
    • (2010) J Clin Oncol , vol.28 , Issue.24 , pp. 3890-3898
    • Lugthart, S.1    Groschel, S.2    Beverloo, H.B.3    Kayser, S.4    Valk, P.J.5    van Zelderen-Bhola, S.L.6
  • 6
    • 79952194399 scopus 로고    scopus 로고
    • De novo acute myeloid leukemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2): A clinicopathologic and cytogenetic study of an entity recently added to the WHO classification
    • Sun J, Konoplev SN, Wang X, Cui W, Chen SS, Medeiros LJ, et al. De novo acute myeloid leukemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification. Mod Pathol. 2011; 24(3): 384-9.
    • (2011) Mod Pathol , vol.24 , Issue.3 , pp. 384-389
    • Sun, J.1    Konoplev, S.N.2    Wang, X.3    Cui, W.4    Chen, S.S.5    Medeiros, L.J.6
  • 7
    • 79960973763 scopus 로고    scopus 로고
    • Risk stratification of intermediate-risk acute myeloid leukemia: Integrative analysis of a multitude of gene mutation and gene expression markers
    • Rockova V, Abbas S, Wouters BJ, Erpelinck CA, Beverloo HB, Delwel R, et al. Risk stratification of intermediate-risk acute myeloid leukemia: Integrative analysis of a multitude of gene mutation and gene expression markers. Blood. 2011; 118(4): 1069-76.
    • (2011) Blood , vol.118 , Issue.4 , pp. 1069-1076
    • Rockova, V.1    Abbas, S.2    Wouters, B.J.3    Erpelinck, C.A.4    Beverloo, H.B.5    Delwel, R.6
  • 8
    • 77951641594 scopus 로고    scopus 로고
    • High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities
    • Groschel S, Lugthart S, Schlenk RF, Valk PJM, Eiwen K, Goudswaard C, et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol. 2010; 28: 2101-7.
    • (2010) J Clin Oncol , vol.28 , pp. 2101-2107
    • Groschel, S.1    Lugthart, S.2    Schlenk, R.F.3    Valk, P.J.M.4    Eiwen, K.5    Goudswaard, C.6
  • 9
    • 0030919163 scopus 로고    scopus 로고
    • Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies
    • Shi G, Weh H-J, Diihrsen U, Zeller W, Hossfeld DK. Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies. Cancer Genet Cytogenet. 1997; 96(1): 58-63.
    • (1997) Cancer Genet Cytogenet , vol.96 , Issue.1 , pp. 58-63
    • Shi, G.1    Weh, H.-J.2    Diihrsen, U.3    Zeller, W.4    Hossfeld, D.K.5
  • 10
    • 84858830672 scopus 로고    scopus 로고
    • New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge
    • Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol. 2012; 30(8): 820-9.
    • (2012) J Clin Oncol , vol.30 , Issue.8 , pp. 820-829
    • Schanz, J.1    Tüchler, H.2    Solé, F.3    Mallo, M.4    Luño, E.5    Cervera, J.6
  • 11
    • 84866621729 scopus 로고    scopus 로고
    • Revised international prognostic scoring system for myelodysplastic syndromes
    • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012; 120(12): 2454-65.
    • (2012) Blood , vol.120 , Issue.12 , pp. 2454-2465
    • Greenberg, P.L.1    Tuechler, H.2    Schanz, J.3    Sanz, G.4    Garcia-Manero, G.5    Solé, F.6
  • 12
    • 84867229265 scopus 로고    scopus 로고
    • Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases
    • Haferlach C, Bacher U, Grossmann V, Schindela S, Zenger M, Kohlmann A, et al. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Genes Chrosomosomes Cancer. 2012; 51: 1079-85.
    • (2012) Genes Chrosomosomes Cancer , vol.51 , pp. 1079-1085
    • Haferlach, C.1    Bacher, U.2    Grossmann, V.3    Schindela, S.4    Zenger, M.5    Kohlmann, A.6
  • 15
    • 84864315640 scopus 로고    scopus 로고
    • Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis
    • Kataoka K, Kurokawa M. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci. 2012; 103(8): 1371-7.
    • (2012) Cancer Sci , vol.103 , Issue.8 , pp. 1371-1377
    • Kataoka, K.1    Kurokawa, M.2
  • 16
    • 34250677675 scopus 로고    scopus 로고
    • The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
    • Wieser R. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene. 2007; 396(2): 346-57.
    • (2007) Gene , vol.396 , Issue.2 , pp. 346-357
    • Wieser, R.1
  • 17
    • 33644760289 scopus 로고    scopus 로고
    • EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements
    • Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N, et al. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements. Genes Chromosomes Cancer. 2006; 45(4): 349-56.
    • (2006) Genes Chromosomes Cancer , vol.45 , Issue.4 , pp. 349-356
    • Poppe, B.1    Dastugue, N.2    Vandesompele, J.3    Cauwelier, B.4    De Smet, B.5    Yigit, N.6
  • 18
    • 84880992553 scopus 로고    scopus 로고
    • The shortest isoform of C/EBP liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model
    • Watanabe-Okochi N, Yoshimi A, Sato I, Ikeda T, Kumano K, Taoka K, et al. The shortest isoform of C/EBP liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model. Blood. 2013; 121(20): 4142-55.
    • (2013) Blood , vol.121 , Issue.20 , pp. 4142-4155
    • Watanabe-Okochi, N.1    Yoshimi, A.2    Sato, I.3    Ikeda, T.4    Kumano, K.5    Taoka, K.6
  • 19
    • 77954533006 scopus 로고    scopus 로고
    • Evi-1 as a critical regulator of leukemic cells
    • Goyama S, Kurokawa M. Evi-1 as a critical regulator of leukemic cells. Int J Hematol. 2010; 91(5): 753-7.
    • (2010) Int J Hematol , vol.91 , Issue.5 , pp. 753-757
    • Goyama, S.1    Kurokawa, M.2
  • 20
    • 70349640956 scopus 로고    scopus 로고
    • Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
    • Konrad TA, Karger A, Hackl H, Schwarzinger I, Herbacek I, Wieser R. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol. 2009; 86(4): 813-22.
    • (2009) J Leukoc Biol , vol.86 , Issue.4 , pp. 813-822
    • Konrad, T.A.1    Karger, A.2    Hackl, H.3    Schwarzinger, I.4    Herbacek, I.5    Wieser, R.6
  • 22
    • 76249131912 scopus 로고    scopus 로고
    • Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
    • Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med. 2010; 16(2): 198-204.
    • (2010) Nat Med , vol.16 , Issue.2 , pp. 198-204
    • Stein, S.1    Ott, M.G.2    Schultze-Strasser, S.3    Jauch, A.4    Burwinkel, B.5    Kinner, A.6
  • 23
    • 0030897009 scopus 로고    scopus 로고
    • International scoring system for evaluating prognosis in myelodysplastic syndromes
    • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997; 89 (6): 2079-88.
    • (1997) Blood , vol.89 , Issue.6 , pp. 2079-2088
    • Greenberg, P.1    Cox, C.2    LeBeau, M.M.3    Fenaux, P.4    Morel, P.5    Sanz, G.6
  • 25
    • 79751531643 scopus 로고    scopus 로고
    • Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype
    • Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia. 2011; 25(2): 266-70.
    • (2011) Leukemia , vol.25 , Issue.2 , pp. 266-270
    • Patnaik, M.M.1    Hanson, C.A.2    Hodnefield, J.M.3    Knudson, R.4    Van Dyke, D.L.5    Tefferi, A.6
  • 26
    • 79953878823 scopus 로고    scopus 로고
    • Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum
    • Breems DA, Löwenberg B. Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum. Hematologica. 2011; 96(4): 491-3.
    • (2011) Hematologica , vol.96 , Issue.4 , pp. 491-493
    • Breems, D.A.1    Löwenberg, B.2
  • 27
    • 78149432321 scopus 로고    scopus 로고
    • Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome
    • Gohring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA, et al. Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010; 116 (19): 3766-9.
    • (2010) Blood , vol.116 , Issue.19 , pp. 3766-3769
    • Gohring, G.1    Michalova, K.2    Beverloo, H.B.3    Betts, D.4    Harbott, J.5    Haas, O.A.6
  • 28
    • 0022383747 scopus 로고
    • Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia
    • Bitter MA, Neilly ME, Le Beau MM, Pearson MG, Rowley JD. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood. 1985; 66(6): 1362-70.
    • (1985) Blood , vol.66 , Issue.6 , pp. 1362-1370
    • Bitter, M.A.1    Neilly, M.E.2    Le Beau, M.M.3    Pearson, M.G.4    Rowley, J.D.5
  • 29
    • 38949205918 scopus 로고    scopus 로고
    • Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
    • Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis. 2008; 40(2): 141-7.
    • (2008) Blood Cells Mol Dis , vol.40 , Issue.2 , pp. 141-147
    • Laricchia-Robbio, L.1    Nucifora, G.2
  • 30
    • 27244460633 scopus 로고    scopus 로고
    • The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity
    • Kilbey A, Alzuherri H, McColl J, Calés C, Frampton J, Bartholomew C. The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity. Br J Haematol. 2005; 130(6): 902-11.
    • (2005) Br J Haematol , vol.130 , Issue.6 , pp. 902-911
    • Kilbey, A.1    Alzuherri, H.2    McColl, J.3    Calés, C.4    Frampton, J.5    Bartholomew, C.6
  • 32
    • 0030765385 scopus 로고    scopus 로고
    • Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy
    • Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood. 1997; 90(8): 2969-77.
    • (1997) Blood , vol.90 , Issue.8 , pp. 2969-2977
    • Estey, E.1    Thall, P.2    Beran, M.3    Kantarjian, H.4    Pierce, S.5    Keating, M.6
  • 33
    • 0035060568 scopus 로고    scopus 로고
    • Realistic pathologic classification of acute myeloid leukemias
    • Arber DA. Realistic pathologic classification of acute myeloid leukemias. Am J Clin Pathol. 2001; 115(4): 552-60.
    • (2001) Am J Clin Pathol , vol.115 , Issue.4 , pp. 552-560
    • Arber, D.A.1
  • 34
    • 0028026968 scopus 로고
    • Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3; 3)(q21; q26)
    • Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3; 3)(q21; q26). Leukemia. 1994; 8(8): 1318-26.
    • (1994) Leukemia , vol.8 , Issue.8 , pp. 1318-1326
    • Fonatsch, C.1    Gudat, H.2    Lengfelder, E.3    Wandt, H.4    Silling-Engelhardt, G.5    Ludwig, W.D.6
  • 35
    • 77950069794 scopus 로고    scopus 로고
    • Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2)
    • Medeiros BC, Kohrt HE, Arber DA. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2). Leuk Res. 2010; 34(5): 594-7.
    • (2010) Leuk Res , vol.34 , Issue.5 , pp. 594-597
    • Medeiros, B.C.1    Kohrt, H.E.2    Arber, D.A.3
  • 36
    • 79955814184 scopus 로고    scopus 로고
    • The inv(3)(q21q26)/t(3; 3)(q21; q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: A study in 39 cases of MDS or AML
    • Haferlach C, Bacher U, Haferlach T, Dicker F, Alpermann T, Kern W, et al. The inv(3)(q21q26)/t(3; 3)(q21; q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. Leukemia. 2011; 25: 874-7.
    • (2011) Leukemia , vol.25 , pp. 874-877
    • Haferlach, C.1    Bacher, U.2    Haferlach, T.3    Dicker, F.4    Alpermann, T.5    Kern, W.6
  • 37
    • 84857711160 scopus 로고    scopus 로고
    • Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: A study on 824 cases with aberrant karyotype
    • Haferlach C, Alpermann T, Schnittger S, Kern W, Chromik J, Schmid C, et al. Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype. Blood. 2012; 119(9): 2122-5.
    • (2012) Blood , vol.119 , Issue.9 , pp. 2122-2125
    • Haferlach, C.1    Alpermann, T.2    Schnittger, S.3    Kern, W.4    Chromik, J.5    Schmid, C.6
  • 38
    • 38149052949 scopus 로고    scopus 로고
    • Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1
    • Yagyu S, Morimoto A, Kakazu N, Tamura S, Fujiki A, Nakase Y, et al. Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1. Cancer Genetics Cytogenetics. 2008; 180(2): 115-20.
    • (2008) Cancer Genetics Cytogenetics , vol.180 , Issue.2 , pp. 115-120
    • Yagyu, S.1    Morimoto, A.2    Kakazu, N.3    Tamura, S.4    Fujiki, A.5    Nakase, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.